Collegium Pharmaceutical, Inc. Deferred Tax Assets, Operating Loss Carryforwards
Collegium Pharmaceutical, Inc. (COLL) had Deferred Tax Assets, Operating Loss Carryforwards of $17.95 million as of 2025-12-31, per its 10-K filed 2026-02-26.
Financial Statements › Notes › Income Taxes › Components of Deferred Tax Assets and Liabilities › Components of Deferred Tax Assets › Deferred Tax Assets, Net › Deferred Tax Assets, Net of Valuation Allowance › Deferred Tax Assets, Gross
us-gaap:DeferredTaxAssetsOperatingLossCarryforwards · last filed 2026-02-26
- 2025-12-31: Deferred Tax Assets, Operating Loss Carryforwards $17.95M.
- 2024-12-31: Deferred Tax Assets, Operating Loss Carryforwards $26.59M.
- 2023-12-31: Deferred Tax Assets, Operating Loss Carryforwards $33.80M.
- 2022-12-31: Deferred Tax Assets, Operating Loss Carryforwards $56.98M.
| Period end | Deferred Tax Assets, Operating Loss Carryforwards |
|---|---|
| 2025-12-31 | $17.95M 10-K · filed 2026-02-26 |
| 2024-12-31 | $26.59M 10-K · filed 2026-02-26 |
| 2023-12-31 | $33.80M 10-K · filed 2025-02-27 |
| 2022-12-31 | $56.98M 10-K · filed 2024-02-22 |
| 2021-12-31 | $31.40M 10-K · filed 2023-02-23 |
| 2020-12-31 | $57.46M 10-K · filed 2022-02-24 |
| 2019-12-31 | $66.55M 10-K · filed 2021-02-25 |
| 2018-12-31 | $82.50M 10-K · filed 2020-02-27 |
| 2017-12-31 | $62.72M 10-K · filed 2019-02-27 |
| 2016-12-31 | $71.05M 10-K · filed 2019-02-27 |
| 2015-12-31 | $38.41M 10-K · filed 2018-03-07 |
| 2014-12-31 | $28.42M 10-K · filed 2016-03-18 |
Similar stocks
| Stock Name | Country | Market Cap | PE Ratio |
|---|---|---|---|
| Faeth Therapeutics, Inc. (FTH) | United States | $0.750B | |
| Design Therapeutics, Inc. (DSGN) | United States | $0.766B | -12.78 |
| Verastem, Inc. (VSTM) | United States | $0.706B | -1.71 |
| Nuvectis Pharma, Inc. (NVCT) | United States | $0.705B | -17.53 |
| IRONWOOD PHARMACEUTICALS INC (IRWD) | United States | $0.694B | 5.37 |
| Wave Life Sciences, Inc. (WVE) | $0.780B | -5.56 | |
| Olema Pharmaceuticals, Inc. (OLMA) | United States | $0.790B | -5.35 |
| Climb Bio, Inc. (CLYM) | United States | $0.683B | -13.03 |
| Aclaris Therapeutics, Inc. (ACRS) | United States | $0.792B | -9.78 |
| GERON CORP (GERN) | United States | $0.803B | -12.14 |